Scientists at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University will test Guardant Health’s technology to detect cancer at early stages in high-risk populations.
Browsing: Research
Northwestern Medicine scientists explore research that has shown how the balanced activities of two protein families regulate gene expression during embryonic development and how mutations that tip this balance lead to cancer.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
Medical student Derek Hsu studies the incidence and outcomes of rare skin disorders in order to develop predictors of mortality, information that could help clinicians prevent and treat the conditions.
A new drug safely and effectively treats patients with ulcerative colitis, according to a recent study co-authored by Northwestern Medicine investigator Stephen Hanauer, MD.
A new study identified a link between gene expression levels and protein aggregation, which can lead to neurodegenerative disorders.
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
New data science initiatives propel Feinberg to “the future of medicine” and individualized patient care.
In a recent study, Northwestern Medicine scientists identified a pathway by which the proteins Foxc1 and Foxc2 regulate signaling in lymphatic vessel growth.
Certain anatomical properties of the brain – not the initial injury – determine most of a patient’s risk of developing chronic pain, according to a new study.